179 related articles for article (PubMed ID: 16854576)
1. Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.
Singh YN; Devkota AK; Sneeden DC; Singh KK; Halaweish F
Phytomedicine; 2007 Feb; 14(2-3):204-8. PubMed ID: 16854576
[TBL] [Abstract][Full Text] [Related]
2. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): effects on rat prostate contractility.
Chua T; Eise NT; Simpson JS; Ventura S
J Ethnopharmacol; 2014 Mar; 152(2):283-91. PubMed ID: 24463033
[TBL] [Abstract][Full Text] [Related]
4. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
Ooi SL; Pak SC
J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of D-004, a lipid extract from Roystonea regia fruits, on prostate hyperplasia induced in rats.
Carbajal D; Molina V; Mas R; Arruzazabala ML
Drugs Exp Clin Res; 2005; 31(5-6):193-7. PubMed ID: 16425975
[TBL] [Abstract][Full Text] [Related]
6. A phytosterol-enriched saw palmetto supercritical CO
Sudeep HV; Venkatakrishna K; Amrutharaj B; Anitha ; Shyamprasad K
BMC Complement Altern Med; 2019 Oct; 19(1):270. PubMed ID: 31623582
[TBL] [Abstract][Full Text] [Related]
7. Saw palmetto and benign prostatic hyperplasia.
Gong EM; Gerber GS
Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
[TBL] [Abstract][Full Text] [Related]
8. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy induced by saw palmetto: a case report.
Villanueva S; González J
Bol Asoc Med P R; 2009; 101(3):48-50. PubMed ID: 20120986
[TBL] [Abstract][Full Text] [Related]
10. Saw palmetto-induced pancreatitis.
Jibrin I; Erinle A; Saidi A; Aliyu ZY
South Med J; 2006 Jun; 99(6):611-2. PubMed ID: 16800417
[TBL] [Abstract][Full Text] [Related]
11. Saw palmetto for prostate disorders.
Gordon AE; Shaughnessy AF
Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
[TBL] [Abstract][Full Text] [Related]
12. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
[TBL] [Abstract][Full Text] [Related]
13. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
[TBL] [Abstract][Full Text] [Related]
14. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
[TBL] [Abstract][Full Text] [Related]
15. Serenoa repens (Saw Palmetto).
Donato A
J Soc Integr Oncol; 2008; 6(1):41-2. PubMed ID: 18302910
[No Abstract] [Full Text] [Related]
16. A possible case of saw palmetto-induced pancreatitis.
Wargo KA; Allman E; Ibrahim F
South Med J; 2010 Jul; 103(7):683-5. PubMed ID: 20531057
[TBL] [Abstract][Full Text] [Related]
17. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gerber GS; Fitzpatrick JM
BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
[TBL] [Abstract][Full Text] [Related]
18. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
Barry MJ; Meleth S; Lee JY; Kreder KJ; Avins AL; Nickel JC; Roehrborn CG; Crawford ED; Foster HE; Kaplan SA; McCullough A; Andriole GL; Naslund MJ; Williams OD; Kusek JW; Meyers CM; Betz JM; Cantor A; McVary KT;
JAMA; 2011 Sep; 306(12):1344-51. PubMed ID: 21954478
[TBL] [Abstract][Full Text] [Related]
19. Saw palmetto for the treatment of men with lower urinary tract symptoms.
Gerber GS
J Urol; 2000 May; 163(5):1408-12. PubMed ID: 10751846
[TBL] [Abstract][Full Text] [Related]
20. A detailed safety assessment of a saw palmetto extract.
Avins AL; Bent S; Staccone S; Badua E; Padula A; Goldberg H; Neuhaus J; Hudes E; Shinohara K; Kane C
Complement Ther Med; 2008 Jun; 16(3):147-54. PubMed ID: 18534327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
